51![Microsoft Word - GOCER-013.doc Microsoft Word - GOCER-013.doc](https://www.pdfsearch.io/img/65beeaa25c74d1919ee48bf0266ee2e8.jpg) | Add to Reading ListSource URL: gilead.comLanguage: English - Date: 2013-02-24 19:40:19
|
---|
52![This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a](https://www.pdfsearch.io/img/7b8a7025738be77471d15ef4702b0f93.jpg) | Add to Reading ListSource URL: gilead.comLanguage: English - Date: 2013-02-25 18:48:52
|
---|
53![HIGHLIGHTS OF PRESCRIBING INFORMATION New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine HIGHLIGHTS OF PRESCRIBING INFORMATION New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine](https://www.pdfsearch.io/img/edac24b8903654c5b7b8ebc9a9a4f81d.jpg) | Add to Reading ListSource URL: www.gilead.comLanguage: English - Date: 2013-10-28 13:55:09
|
---|
54![PATIENT INFORMATION VIREAD® (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information. PATIENT INFORMATION VIREAD® (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information.](https://www.pdfsearch.io/img/5f8ba944616b3d04fd869162a57ec0f0.jpg) | Add to Reading ListSource URL: www.gilead.comLanguage: English - Date: 2015-05-29 13:25:40
|
---|
55![Microsoft Word - FPC QHP Policy Guide Febdoc Microsoft Word - FPC QHP Policy Guide Febdoc](https://www.pdfsearch.io/img/8853f5ad65d9d66c9a93ef11aab0ccd4.jpg) | Add to Reading ListSource URL: fairpricingcoalition.orgLanguage: English - Date: 2014-02-05 17:34:29
|
---|
56![ISENTRESS ™(raltegravir), in Combination with tenofovir /lamivudine, Showed Durable and Potent Antiretroviral Activity in Treatment Naïve, HIV-1 Infected Patients, with Similar HIV RNA Reduction to Efavirenz in Combin ISENTRESS ™(raltegravir), in Combination with tenofovir /lamivudine, Showed Durable and Potent Antiretroviral Activity in Treatment Naïve, HIV-1 Infected Patients, with Similar HIV RNA Reduction to Efavirenz in Combin](https://www.pdfsearch.io/img/ddc55d8f2e56e1033dae09080f55139a.jpg) | Add to Reading ListSource URL: www.msd-italia.itLanguage: Italian - Date: 2013-02-13 08:58:47
|
---|
57![Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia](https://www.pdfsearch.io/img/d89c92398af08a8b010529fbde42b9cf.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
58![PATIENT INFORMATION VIREAD® (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information. PATIENT INFORMATION VIREAD® (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information.](https://www.pdfsearch.io/img/a16fe28676912b930bda4850553ea0f8.jpg) | Add to Reading ListSource URL: www.gilead.comLanguage: English - Date: 2015-05-29 07:25:40
|
---|
59![FOR IMMEDIATE RELEASE Tokyo, March 2, 2015 JT and Torii sign agreement to market two new tenofovir alafenamide (TAF)-based anti-HIV drugs in Japan FOR IMMEDIATE RELEASE Tokyo, March 2, 2015 JT and Torii sign agreement to market two new tenofovir alafenamide (TAF)-based anti-HIV drugs in Japan](https://www.pdfsearch.io/img/790d25ddd4b2ee0e5e51d8aef73cb9c5.jpg) | Add to Reading ListSource URL: www.jt.comLanguage: English - Date: 2015-03-01 21:32:08
|
---|
60![IN THE UNITED STATES PATENT AND TRADEMARK OFFICE PATENT NO.: 5,935,946 IN THE UNITED STATES PATENT AND TRADEMARK OFFICE PATENT NO.: 5,935,946](https://www.pdfsearch.io/img/0a5bddea867edc99c4e7df019681a337.jpg) | Add to Reading ListSource URL: www.pubpat.orgLanguage: English - Date: 2007-12-21 07:53:28
|
---|